CONNECTIVITY

CONNECTIVITY

TOWARDS A NEW STANDARD OF CARE WITH APTAR PHARMA’S DIGITAL HEALTH

Adam Shain discusses how Aptar is building on the progress made in connected drug delivery devices to help realise their full potential by developing an open, end-to-end platform that will enable healthcare stakeholders to take a holistic view of the full drug delivery journey.

CONNECTIVITY

MATERIAL SELECTION FOR NEXT-GENERATION CONNECTED MEDICAL ELECTRONICS

Miriam Kingsley, Marcus Jarman-Smith and Thomas Billings highlight the growing array of applications for high-performance polymers in electronic and connected medical devices and how proper material selection is crucial, providing a guide to successful material selection, going on to showcase its APTIV™ PEEK polymer film, which is well suited to meet the specific demands of next-generation connected medical devices.

CONNECTIVITY

Dr Andreas Alt

Sensirion

HOW MINIATURISED LIQUID FLOW SENSORS ARE REVOLUTIONISING SUBCUTANEOUS DRUG DELIVERY

Andreas Alt and Susanne Pianezzi describe the drivers accelerating industry trends towards both wearable subcutaneous injection devices and connecting such devices to monitor patient dosing, providing a number of benefits.

EXPERT VIEW

Natalie Shortt

“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE

Natalie Shortt discusses the considerations and steps to take when planning usability engineering efforts for software as a medical device.

CONNECTIVITY

Dr Carola Fuchs

PARI

eFLOW TECHNOLOGY NEBULISERS WITH DIGITAL THERAPY MANAGEMENT: THE PARI CONNECT ECO-SYSTEM

Carola Fuchs and Simon Buchner describe PARI’s new nebuliser and digital Connect eco-system and how it supports patients, directly and indirectly, through carefully considered device usability in combination with digital therapy management solutions.

INTERVIEW

Arnaud Guillet

Biocorp

Interview: Arnaud Guillet, Biocorp

In this exclusive interview with ONdrugDelivery, Arnaud Guillet discusses Mallya, Biocorp’s connected clip-on for pen injectors, including Mallya’s successful launch in multiple countries this year, the factors that have played into the device’s success, and the future for Mallya, Biocorp and connectivity in the drug delivery industry.

CONNECTIVITY

Philippe Müller

Ypsomed

YPSOMATE ON – GO FOR SIMPLY CONNECTED

Philippe Müller and Silas Mächler discuss the benefits of integrated digital therapy management systems and the role of YpsoMate On –  the newest addition to Ypsomed’s connected device portfolio, and the world’s first prefilled autoinjector with integrated connectivity that automatically logs injections on the user’s therapy management app.

CONNECTIVITY

Rebecca Beck

BD (Becton Dickinson & Company)

TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS

Rebecca Beck and Hervé Monchoix discuss how stakeholder needs are driving the development of a new, connected injection device from BD, to support decentralised and hybrid clinical trials.

EARLY INSIGHT

Brad Moore

Global Cannabis Applications Corp

USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY

Brad Moore and Tim Morch describe GCAC’s technology offering, a blockchain-based software system that is able to transparently track the progress of medical cannabis from cultivation through to consumption.

CONNECTIVITY

Andreas Meliniotis

Vectura

MAKING THE CONNECTION BETWEEN EFFICACY AND ENVIRONMENTAL SUSTAINABILITY

Andreas Meliniotis looks at the factors that should be considered when designing devices with a view to sustainable connectivity.

PULMONARY

Edgar Hernan Cuevas Brun

HCmed Innovations

DELIVERING SUSPENSIONS WITH MESH TECHNOLOGY

Edgar Hernan Cuevas Brun and Yuan-Ming Hsu discuss the performance of mesh nebulisers for the delivery of suspensions in inhalation therapy.

SUSTAINABILITY

Emil Fraenkel

Phillips-Medisize

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT

Emil Fraenkel and Bjarne Sørensen consider the sustainability of re-usable and disposable autoinjectors, its implications in adding connectivity to drug delivery devices and how it has been an important consideration for Phillips-Medisize in the development of the Aria re-usable autoinjector. 

INJECTION

Dr Kate Hudson-Farmer

Phillips-Medisize

HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS

Kate Hudson-Farmer discusses how a new electronic reusable autoinjector – the Aria Smart Autoinjector from Phillips-Medisize – has been designed and user-tested to challenge the preconceived ease-of-use notions about electronic autoinjectors, in addition to addressing how macro trends and personal consumer subtleties could become increasingly important in creating a competitive position as devices seek to improve patient engagement.

EXPERT VIEW

Enrico Denna

USING SIMULATION AND MODELLING VERSUS PROTOTYPING FOR MEDICAL RADIO FREQUENCY DESIGN

Enrico Denna looks at the advantages of a simulation and modelling approach over prototyping for the design of medical products.

WEARABLES

Wim Vos

Celanese

VECTRA^® MT^® LCP BRINGS THE ADVANTAGES OF LIQUID CRYSTAL POLYMERS TO WEARABLE INJECTORS

Wim Vos, Dave Pellegrino and Rob Haley discuss the myriad benefits of Vectra^® MT^® LCP, Celanese’s medical-grade liquid crystal polymer, for wearable injection devices, including improved patient comfort, greater design flexibility and reduced processing costs.

EXPERT VIEW

Tim Resker

OPTIONS FOR ACTIVATION OF BATTERY-OPERATED MEDICAL DEVICES

Tim Resker looks at new technologies for powering on battery-operated drug delivery devices while considering battery drain, ingress protection and user-friendliness.

CONNECTIVITY

Marcus Jarman-Smith

Victrex

CONNECTED DEVICES CHALLENGE: HOW TO DEVELOP CONCEPT DEVICES WITH PEEK POLYMERS

Marcus Jarman-Smith, Adam Salmen, John Devine, Ernst Hupkes and Dennis Freie discuss the value of PEEK, a high-performance polymer, in drug delivery device design, using two concept devices – an on-body patch pump and vaporiser inhaler.

INDUSTRIALISATION

Jens Schou Christensen

Stevanato Group

HOW DIGITISATION IS DELIVERING COMPETITIVE ADVANTAGE IN DEVICE ASSEMBLY

Jens Schou Christensen and Sebastian Berninger-Lund present the business case for the wider implementation of digitisation and the greater use of data to deliver assembly line improvements.

INDUSTRIALISATION

Napoleon Monroe

New Directions Technology Consulting

INDUSTRIALISATION OF DRUG DELIVERY BEYOND MANUFACTURING

Napoleon Monroe considers the impact of the changing technological landscape on how industrialisation in the healthcare industry is evolving, with reference to the idea of “patients as consumers” and how the relationship between consumers, information and industry has evolved in other sectors, such as tech and retail – and how big players in those sectors are looking to move into and disrupt healthcare.

GI/ORAL

Gary Pond

Colorcon

SMARTER MEDICINES TO SECURE PRODUCTS AND PROMOTE PATIENT ENGAGEMENT

Gary Pond looks at digital authentication and discusses how on-dose microtaggants can provide a high level of security in authenticating tablets and capsules in the fight against counterfeit products.

CONNECTIVITY

Arnaud Guillet

Biocorp

BIOCORP’S MALLYA – CHRONICLING A SUCCESS STORY

 Arnaud Guillet and colleagues from across the industry, discuss Bicorp’s Mallya add-on device for disposable insulin pens, providing details on the main country launches and key software integrations, as well as presenting initial feedback from healthcare professionals and patients.

CONNECTIVITY

Napoleon Monroe

New Directions Technology Consulting

PATENTS ARE IMPORTANT FOR SMART HEALTHCARE PRODUCTS

Napoleon Monroe discusses the value of internet-connected smart devices in present-day healthcare, and introduces the mMed patent portfolio, of which Mr Monroe is the sole inventor, and which contains five US patents for key connected health technologies.

EXPERT VIEW

Dr Ben Cox

THE POWER OF ONBOARDING: BUILDING PERSUASIVE USER EXPERIENCES FOR COMPANION APPS

Ben Cox discusses the value of onboarding in drug delivery device companion apps, and how it is a key component of converting a one-time user to a repeat user, unlocking the true value of companion apps as a tool for combating poor adherence to medications and gathering high-quality data.

CONNECTIVITY

Josh Hopkins

Noble

HOW DIGITAL MEDICAL DEVICES ARE MEETING THE CHALLENGES OF CLINICAL TRIALS

Josh Hopkins discusses the challenges that have been present in conducting clinical trials at a central brick-and-mortar location since their inception, and how modern digitisation presents an opportunity to improve clinical trial methodology by liberating it from the need for an in-person central study site via the use of digital medical devices and technologies.

CONNECTIVITY

Matthew Sarkar

Sagentia Innovation

IMPROVING PATIENT OUTCOMES WITH ADVANCED DIGITAL BIOMARKERS

Matthew Sarkar and Imantha Samaranayake consider the contribution digital biomarker devices make towards healthcare and the challenges faced by the evolution of such devices.

CONNECTIVITY

Christina Philpott

Recipe Design

MEANING-CENTRED PRODUCT DEVELOPMENT: THE KEY TO SUCCESSFUL CONNECTED DISEASE MANAGEMENT

Christina Philpott, Miles Hawley and Natasha French, discuss the future of connected disease management and the potential benefits for asthma treatment.

CONNECTIVITY

John Whitehouse

DCA

CYBERSECURITY AND CONNECTED DRUG DELIVERY – AN INTEGRATED RISK-BASED APPROACH

John Whitehouse, Rob Veasey and Shane Day, discuss the value of integrating cybersecurity into a holistic, multidisciplinary approach to risk management for connected medical devices.

CONNECTIVITY

Adam Shain

Aptar Pharma

PUTTING THEIR HEALTH IN THEIR HANDS: ENHANCING RESPIRATORY PATIENT OUTCOMES THROUGH DIGITAL THERAPEUTICS

Adam Shain discusses the role digital therapeutics play in respiratory patient outcomes and looks at the potential for expansion into other therapy areas.

CONNECTIVITY

Dr Young Kim

Celanese

SPECIALTY LCP COMPOUNDS FOR ELECTRONICS INTEGRATION IN CONNECTED MEDICAL DEVICES

Young Kim, Don DeMello and Philip Wilson, discuss the benefits of recent advances in liquid crystal polymer for connected medical devices.

CONNECTIVITY

Bjarne Sørensen

Phillips-Medisize

RE-USABLE ELECTRONIC AUTOINJECTOR – FLEXIBLE PERFORMANCE

Bjarne Sørensen discusses the ability of electronically driven injection devices to cater for a broad range of liquid drug properties within a single device platform.

INJECTION

Jimmy Fan

CC Bio

I-PLATFORM DEVICE: THE SMART DEVICE WITH APTITUDE

Jimmy Fan outlines the capabilities and benefits of the I-Platform smart drug delivery device.

CONNECTIVITY

Arnaud Guillet

Biocorp

INJAY: SIMPLE BY CHOICE, ADAPTABLE BY DESIGN

Arnaud Guillet discusses Biocorp’s Injay solution for adding connectivity to a wide variety of PFS devices, focusing on how Injay’s designed-in simplicity and flexibility makes it easily applicable across the spectrum of PFS platforms on the market today.

CONNECTIVITY

Mauro Citterio

Berry Global Healthcare

RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO

Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder inhaler, based on Berry’s commercialised RS01 inhaler and Amiko’s Respiro digital health platform.

EXPERT VIEW

George I’ons

CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION

George I’ons discusses the challenges developing connected devices presents to key market stakeholders when it comes to successful rollout and implementation. Additionally, he considers the perspectives of these market players, as well as the patients themselves, with respect to how connected drug delivery devices can help them to better achieve their desired outcomes.

CONNECTIVITY

Mr Michael Kiely

Jabil Healthcare

MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE

Michael Kiely, Laura Marsden, Peter Stringer, and David Boyle discuss the design challenges at the electromechanical interface and encourage manufacturers to adopt a standardised approach for connecting medical devices to the cloud.

CONNECTIVITY

Neil Williams

Phillips-Medisize

THE CHANGING FACE OF CONNECTED HEALTH IN THE TIME OF COVID-19

Neil Williams and Angela R Eder both of Phillips-Medisize, discuss how the current pandemic is transforming the adoption of connected health.

CONNECTIVITY

Arnaud Guillet

Biocorp

MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE

Arnaud Guillet reviews the Mallya connected device platform, from the origins of the project to the current success in diabetes and deployment in other fields, and introduces the promising next-generation Mallya.

CONNECTIVITY

Marcus Bates

Aptar Pharma

THE COVID-19 CATALYST: HOW A GLOBAL PANDEMIC IS ACCELERATING THE NEED FOR DIGITAL HEALTH

Marcus Bates discusses the positive impact covid-19 has had on the digital health industry, including the acceleration and development of remote patient services.